Atea Pharmaceuticals(AVIR) - 2025 Q4 - Earnings Call Transcript

Atea Pharmaceuticals (NasdaqGS:AVIR) Q4 2025 Earnings call March 05, 2026 04:30 PM ET Company ParticipantsAndrea Corcoran - CFO and EVP of LegalArantxa Horga - Chief Medical OfficerJanet Hammond - Chief Development OfficerJean-Pierre Sommadossi - CEO and FounderJohn Vavricka - Chief Commercial OfficerJonae Barnes - SVP of Investor Relations and Corporate CommunicationsJonathan Miller - Managing Director of Biotech and Pharma Equity ResearchConference Call ParticipantsAndy Hsieh - Biotech Research AnalystNon ...